Czech National Bank Has $8.73 Million Stock Holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Czech National Bank raised its position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 15.0% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 93,026 shares of the company’s stock after purchasing an additional 12,147 shares during the period. Czech National Bank’s holdings in GE HealthCare Technologies were worth $8,730,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in GEHC. Central Pacific Bank Trust Division raised its holdings in shares of GE HealthCare Technologies by 8.4% during the 3rd quarter. Central Pacific Bank Trust Division now owns 5,348 shares of the company’s stock worth $502,000 after buying an additional 415 shares in the last quarter. M&R Capital Management Inc. acquired a new position in GE HealthCare Technologies during the third quarter worth about $33,000. Sanctuary Advisors LLC acquired a new position in GE HealthCare Technologies during the second quarter worth about $1,382,000. Cetera Investment Advisers lifted its holdings in shares of GE HealthCare Technologies by 7.7% in the second quarter. Cetera Investment Advisers now owns 73,713 shares of the company’s stock worth $5,744,000 after acquiring an additional 5,239 shares during the last quarter. Finally, Granite Bay Wealth Management LLC acquired a new stake in shares of GE HealthCare Technologies in the 2nd quarter valued at approximately $534,000. 82.06% of the stock is currently owned by institutional investors.

Insider Activity

In other news, CEO Thomas J. Westrick sold 2,750 shares of the business’s stock in a transaction that occurred on Wednesday, August 7th. The stock was sold at an average price of $80.78, for a total transaction of $222,145.00. Following the completion of the sale, the chief executive officer now owns 17,509 shares in the company, valued at $1,414,377.02. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. 0.27% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

Several equities analysts recently commented on GEHC shares. JPMorgan Chase & Co. began coverage on shares of GE HealthCare Technologies in a research note on Monday, September 9th. They issued a “neutral” rating and a $90.00 price objective for the company. Stifel Nicolaus increased their price target on GE HealthCare Technologies from $100.00 to $102.00 and gave the company a “buy” rating in a research note on Monday, September 30th. BTIG Research upgraded GE HealthCare Technologies from a “neutral” rating to a “buy” rating and set a $100.00 price objective on the stock in a research report on Wednesday, September 18th. Redburn Atlantic upgraded GE HealthCare Technologies to a “strong-buy” rating in a research report on Thursday, August 1st. Finally, UBS Group cut GE HealthCare Technologies from a “neutral” rating to a “sell” rating and reduced their price target for the stock from $84.00 to $74.00 in a report on Thursday, September 26th. One analyst has rated the stock with a sell rating, five have issued a hold rating, seven have issued a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $94.23.

GE HealthCare Technologies Trading Up 1.7 %

NASDAQ GEHC opened at $91.42 on Friday. GE HealthCare Technologies Inc. has a one year low of $62.35 and a one year high of $94.55. The company has a debt-to-equity ratio of 1.05, a current ratio of 1.06 and a quick ratio of 0.82. The business has a 50 day simple moving average of $86.25 and a 200 day simple moving average of $83.38. The stock has a market capitalization of $41.73 billion, a P/E ratio of 26.73, a P/E/G ratio of 3.40 and a beta of 1.18.

GE HealthCare Technologies (NASDAQ:GEHC) last released its quarterly earnings data on Wednesday, July 31st. The company reported $1.00 earnings per share for the quarter, beating the consensus estimate of $0.98 by $0.02. The company had revenue of $4.84 billion during the quarter, compared to analyst estimates of $4.88 billion. GE HealthCare Technologies had a net margin of 8.10% and a return on equity of 25.26%. GE HealthCare Technologies’s revenue for the quarter was up .5% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.92 EPS. Research analysts expect that GE HealthCare Technologies Inc. will post 4.26 earnings per share for the current year.

GE HealthCare Technologies Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 15th. Stockholders of record on Friday, October 18th will be given a dividend of $0.03 per share. The ex-dividend date is Friday, October 18th. This represents a $0.12 dividend on an annualized basis and a dividend yield of 0.13%. GE HealthCare Technologies’s dividend payout ratio (DPR) is presently 3.51%.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.